Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingwei Luo

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
NPJ Digital Medicine|September 1, 2025
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinomaYang Liu, Wenbin Yan, Yupei Chen, et al.
Oral Oncology|April 26, 2025
Conditional survival and dynamic failure hazard of oral cavity squamous cell carcinoma: Shedding light on the optimization of treatment and surveillanceNuo Yu, Yuchao Ma, Lin Li, et al.
Head & Neck|June 20, 2025
Patterns of Regional Failure in Patients With Oral Cavity Squamous Cell Carcinoma After Radical Surgery: Insight for Neck Management OptimizationLin Li, Yuchao Ma, Xin Guo, et al.
Journal of the National Cancer Center|July 22, 2024
Pretreatment systemic immune-inflammation index predicts survival for non-metastatic nasopharyngeal carcinoma: two independent institutional studiesFengge Zhou, Liting Liu, Xiaodong Huang, et al.
Frontiers in Oncology|August 28, 2020
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical TrialXiaodong Huang, Xiaozhong Chen, Chong Zhao, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
NPJ Digital Medicine|September 1, 2025
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinomaYang Liu, Wenbin Yan, Yupei Chen, et al.
Oral Oncology|April 26, 2025
Conditional survival and dynamic failure hazard of oral cavity squamous cell carcinoma: Shedding light on the optimization of treatment and surveillanceNuo Yu, Yuchao Ma, Lin Li, et al.
Head & Neck|June 20, 2025
Patterns of Regional Failure in Patients With Oral Cavity Squamous Cell Carcinoma After Radical Surgery: Insight for Neck Management OptimizationLin Li, Yuchao Ma, Xin Guo, et al.
Journal of the National Cancer Center|July 22, 2024
Pretreatment systemic immune-inflammation index predicts survival for non-metastatic nasopharyngeal carcinoma: two independent institutional studiesFengge Zhou, Liting Liu, Xiaodong Huang, et al.
Frontiers in Oncology|August 28, 2020
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical TrialXiaodong Huang, Xiaozhong Chen, Chong Zhao, et al.
Pageof 8